Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine.

Hui G, Hashimoto C. Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine. Vaccine. 2007 Sep 04; 25(36):6598-603.

View in: PubMed

subject areas

Adjuvants, Immunologic
Animals
Antibodies, Protozoan
Antibody Formation
Enzyme-Linked Immunosorbent Assay
Female
Immunoglobulins
Interleukin-6
Malaria Vaccines
Mice
Mice, Inbred C57BL
Mice, Knockout
Plasmodium falciparum

authors with profiles

George S.N. Hui, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support